Artificial Pancreas Device System Market Outlook Through 2030: Understanding The Growth Opportunity
Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Artificial Pancreas Device System Market Size Outlook: How Quickly Will Revenue Expand Through 2030?
The artificial pancreas device system market size has experienced rapid growth in recent years. It is forecast to expand from $2.06 billion in 2025 to $2.35 billion in 2026, achieving a compound annual growth rate (CAGR) of 13.9%. The market’s past growth can be attributed to the increasing prevalence of diabetes, the early adoption of insulin pump technologies, the wider expansion of continuous glucose monitoring usage, enhancements in medical sensor accuracy, and a rising awareness of automated diabetes management.
The artificial pancreas device system market is projected to undergo significant expansion over the next few years. It is predicted to attain a value of $3.92 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 13.7%. This projected increase is propelled by factors such as the escalating demand for fully automated glucose regulation, increasing investments in digital diabetes care, the broadening scope of remote patient monitoring, a heightened focus on personalized insulin therapy, and enhanced regulatory support for advanced diabetes devices. Prominent trends anticipated during this period encompass the growing uptake of closed-loop glucose control systems, increased integration of continuous glucose monitoring (CGM) with insulin pumps, a rise in the application of predictive algorithms for insulin delivery, the expansion of wearable devices for diabetes management, and an amplified emphasis on patient-centric automation.
Get A Free Sample Report With In-Depth Market Insights:
Artificial Pancreas Device System Market Development Factors: What’s Supporting Demand?
The expanding occurrence of pancreatic cancer is anticipated to drive the artificial pancreas device system market’s future growth. Pancreatic cancer is a malignant tumor originating in the pancreas, an organ situated behind the stomach. This condition is influenced by a combination of lifestyle, genetic, medical, and environmental factors, along with genetic mutations leading to hereditary pancreatitis, which can cause chronic inflammation of the pancreas. An artificial pancreas device system (APDS) is primarily designed to assist individuals with diabetes in managing their blood sugar levels by automatically monitoring glucose and delivering the appropriate amount of insulin. For instance, in March 2024, Cancer Australia, a government agency, estimated that 4,506 new cases of pancreatic cancer were diagnosed in 2023, marking an increase from the 3,751 cases reported over the past five years. Consequently, the rising prevalence of pancreatic cancer is fueling the expansion of the artificial pancreas device system market.
Artificial Pancreas Device System Market Segments: Where Is Growth Concentrated?
The artificial pancreas device system market covered in this report is segmented –
1) By Device Type: Threshold Suspend Device Systems, Control-To-Range Systems, Control-To-Target Systems
2) By Treatment Type: Bi-Hormonal, Insulin Only, Hybrid
3) By End-User: Hospitals, Medical Centers, Other End-Users
Subsegments:
1) By Threshold Suspend Device Systems: Insulin Pump with Threshold Suspend, Continuous Glucose Monitoring (CGM) Integrated Systems
2) By Control-To-Range Systems: Hybrid Closed-Loop Systems, Insulin Delivery Systems with Range Control, Real-Time Glucose Adjustment Systems
3) By Control-To-Target Systems: Fully Closed-Loop Artificial Pancreas Systems, Insulin Pumps with Targeted Glucose Control, Automated Glucose Regulation Systems
Artificial Pancreas Device System Market Transformation Trends: What Innovations Are Driving Change?
Leading companies within the artificial pancreas device system market are actively developing automated insulin delivery systems, aiming to enhance diabetes management by continuously monitoring blood glucose levels and administering appropriate insulin doses automatically. These automated insulin delivery systems are designed to mimic the function of a healthy pancreas, thereby reducing the burden of constant blood sugar monitoring and manual insulin administration for individuals with diabetes. For instance, in May 2023, Beta Bionics, a US-based medical equipment manufacturing company, obtained FDA 510(k) clearance for its iLet Insulin-Only Bionic Pancreas System, an automated insulin delivery device. This particular artificial pancreas system is engineered to autonomously determine and deliver insulin doses to control blood glucose levels. Operating as a closed-loop system, it automatically adjusts insulin delivery based on the user’s glucose levels, which are measured by a connected continuous glucose monitor (CGM). The system only requires the user’s body weight and an estimate of meal size to automatically adjust insulin delivery.
Artificial Pancreas Device System Market Key Participants And Competitive Landscape
Major companies operating in the artificial pancreas device system market are Medtronic plc, Abbott Laboratories, DexCom Inc., Insulet Corporation, Tandem Diabetes Care Inc., Roche Diabetes Care, Ypsomed, SOOIL Development, Beta Bionics Inc., Bigfoot Biomedical Inc., Diabeloop SA, Inreda Diabetic B.V., Defymed SAS, DreaMed Diabetes Ltd., Medtrum Technologies Inc., EOFlow Co. Ltd., Cellnovo, Pancreum Inc., Admetsys Corporation, GlucoModicum, MicroTech Medical
View The Full Artificial Pancreas Device System Market Report:
Artificial Pancreas Device System Market Global Footprint: Which Region Leads The Market?
North America was the largest region in the artificial pancreas device system market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial pancreas device system market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
